Manzo Pharmaceuticals, Inc. (MNZO)

Market Cap	11.00K +899.5%
Revenue (ttm)	n/a +2.2%
Net Income	7.75M
EPS	1.91
Shares Out	1.10B
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	600
Open	n/a
Previous Close	0.0001
Day's Range	n/a
52-Week Range	n/a
Beta	-49.59
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Manzo Pharmaceuticals

Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporat...

• Industry: Shell Companies
• Sector: Financials
• Founded: 1980
• Employees: 12
• Stock Exchange: OTCMKTS
• Ticker Symbol: MNZO

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 9, 2026

Data Sources Report a data error